The hunt for a natural molecule that can release cellular energy

All cells in the human body, and the motions they enable, from our beating hearts to our wiggling toes, use energy generated by a molecule called ATP. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

It is relevant because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: Add as preferred source Non-coding RNA Research (2026).

Researchers at The Ohio State University have gotten one step closer to that possibility by identifying the first noncoding RNA derived from human cells that can bind to ATP. Guo is a pioneer in the discovery of functional noncoding RNAs, tiny RNA molecules lacking instructions for building proteins, that constitute more than 98% of the human genome.

He is optimistic that a noncoding RNA that functions as an ATPase can be found in the genome and foresees using such a molecule for a new class of therapeutic nanomaterials. This new work builds on prior research in Guo's lab that led to the identification of a viral RNA that could bind to ATP.

Margaret Bohmer et al, Discovery of a G-rich ultra stable human ncRNA G-quadruplex that binds ATP, Non-coding RNA Research (2026). Kai Jin et al, Illustration of the variable 1D sequences but conserved 2D and 3D structures of different ncRNA nanostructures for tracking the evolution and origin of organisms.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

BSc Life Sciences & Ecology. Well-traveled with unique perspectives on science and language.

Because this item comes through Phys. org Biology as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source